Pauline Maki, PhD, discusses real-world OPTION-VMS data linking fezolinetant to improvements in menopausal VMS, depression, ...
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use. Postmenopausal women using hormone therapy had ...
Women with moderate to severe vasomotor symptoms (VMS) who received elinzanetant (Lynkuet; Bayer) were more likely than those ...
Women who reached menopause before age 40 years had a higher long-term risk of cardiovascular disease (CVD) and coronary ...
CBT is an evidence-based, nonhormonal option endorsed by the National Institutes of Health and The Menopause Society for ...
Capsule-sponge DNA methylation test boosts Barrett’s screening access, showing high accuracy, strong tolerability, and ...
The American College of Obstetricians & Gynecologists (ACOG) has published new clinical guidance on managing menopause-related vasomotor symptoms (VMS), sleep disturbance, and moo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results